Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression.

We reported that the lipoapoptosis of beta-cells observed in fat-laden islets of obese fa/fa Zucker Diabetic Fatty (ZDF) rats results from overproduction of ceramide, an initiator of the apoptotic cascade and is induced by long-chain fatty acids (FA). Whereas the ceramide of cytokine-induced apoptosis may be derived from sphingomyelin hydrolysis, FA-induced ceramide overproduction seems to be derived from FA. We therefore semiquantified mRNA of serine palmitoyltransferase (SPT), which catalyzes the first step in ceramide synthesis. It was 2-3-fold higher in fa/fa islets than in +/+ controls. [3H]Ceramide formation from [3H]serine was 2.2-4. 5-fold higher in fa/fa islets. Triacsin-C, which blocks palmitoyl-CoA synthesis, and L-cycloserine, which blocks SPT activity, completely blocked [3H]ceramide formation from [3H]serine. Islets of fa/fa rats are unresponsive to the lipopenic action of leptin, which normally depletes fat and prevents FA up-regulation of SPT. To determine the role of leptin unresponsiveness in the SPT overexpression, we transferred wild type OB-Rb cDNA to their islets; now leptin completely blocked the exaggerated FA-induced increase of SPT mRNA while reducing the fat content. Beta-cell lipoapoptosis was partially prevented in vivo by treating prediabetic ZDF rats with L-cycloserine for 2 weeks. Ceramide content and DNA fragmentation both declined 40-50%. We conclude that lipoapoptosis of ZDF rats is mediated by enhanced ceramide synthesis from FA and that blockade by SPT inhibitors prevents lipoapoptosis.

[1]  M. Prentki,et al.  Molecular or Pharmacologic Perturbation of the Link between Glucose and Lipid Metabolism Is without Effect on Glucose-stimulated Insulin Secretion , 1998, The Journal of Biological Chemistry.

[2]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[3]  C. Newgard,et al.  OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Hanada,et al.  A Mammalian Homolog of the Yeast LCB1 Encodes a Component of Serine Palmitoyltransferase, the Enzyme Catalyzing the First Step in Sphingolipid Synthesis* , 1997, The Journal of Biological Chemistry.

[5]  W. Stoffel,et al.  Human and murine serine-palmitoyl-CoA transferase--cloning, expression and characterization of the key enzyme in sphingolipid synthesis. , 1997, European journal of biochemistry.

[6]  C. Newgard,et al.  Engineering of Glycerol-stimulated Insulin Secretion in Islet Beta Cells , 1997, The Journal of Biological Chemistry.

[7]  R. Unger,et al.  Role of nitric oxide in obesity-induced beta cell disease. , 1997, The Journal of clinical investigation.

[8]  C. Newgard,et al.  Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Newgard,et al.  Direct antidiabetic effect of leptin through triglyceride depletion of tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Unger,et al.  Increased Lipogenic Capacity of the Islets of Obese Rats: A Role in the Pathogenesis of NIDDM , 1997, Diabetes.

[11]  T. Murakami,et al.  Substitution at codon 269 (glutamine --> proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. , 1996, Biochemical and biophysical research communications.

[12]  M. Phillips,et al.  Leptin receptor missense mutation in the fatty Zucker rat , 1996, Nature Genetics.

[13]  Kaplan Da.  Is it a wonderful life , 1996 .

[14]  M. Mcdaniel,et al.  Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide. , 1996, Biochimica et Biophysica Acta.

[15]  Å. Sjöholm.  Ceramide inhibits pancreatic β‐cell insulin production and mitogenesis and mimics the actions of interleukin‐1β , 1995 .

[16]  J. H. Johnson,et al.  Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[18]  A. Merrill,et al.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. , 1991, The Journal of biological chemistry.

[19]  D. D. Jones,et al.  An update of the enzymology and regulation of sphingomyelin metabolism. , 1990, Biochimica et biophysica acta.

[20]  D. Mason,et al.  Standardization of Insulin Secretion from Pancreatic Islets: Validation of a DNA Assay , 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[21]  K. Sundaram,et al.  Inhibition of Sphingolipid Synthesis by Cycloserine In Vitro and In Vivo , 1984, Journal of neurochemistry.

[22]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[23]  Nils Welsh,et al.  Interleukin-1 (cid:98) -induced Ceramide and Diacylglycerol Generation May Lead to Activation of the c-Jun NH 2 -terminal Kinase and the Transcription Factor ATF2 in the Insulin-producing Cell Line RINm5F* , 1996 .